FDA Inspection
Shilpa Medicare LimitedShilpa Medicare Limited – FDA Inspection, Feb 25, 2020
Record Details
This FDA Inspection record concerns Shilpa Medicare Limited, with an inspection on February 25, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Shilpa Medicare Limited
- Inspection Date
- February 25, 2020
- Product Type
- Drugs
View Company Profile
ID · 697d1298-32ab-4346-bb72-ace82de70319
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1121634
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Enforcement
- Warning Letter
Other FDA inspections of Shilpa Medicare Limited
7| Date | Classification | Office | Project area |
|---|---|---|---|
| November 21, 2025 | Not classified | Office of Inspections and Investigations | |
| November 9, 2023 | Not classified | Office of Inspections and Investigations | |
| September 6, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 30, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 28, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Shilpa Medicare Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.